A daily dose of vitamin B3 reduced inflammation in the lungs of patients with COPD, Danish researchers report.  "This is ...

Type 2 diabetes (T2D) and obesity (OB) are associated with chronic low-grade inflammation and increased fracture risk. In vitro studies showed that inflammation induces bone erosion and inhibits bone ...

Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 (AA, AF and FF) ...

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

The US Food and Drug Administration has approved bimekizumab, a humanized interleukin (IL)-17A and IL-17F antagonist, for the ...

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

FDA approves UCB's Bimzelx for adults with moderate to severe hidradenitis suppurativa, supported by Phase 3 trials showing significant symptom improvement.

We live longer and longer, and as we age, a lot of us develop a series of health issues and chronic diseases, including ...

A live webcast link for the Evercore ISI HealthCONx Conference fireside chat will be available at https://investors.werewolftx.com/news-and-events/events. An archived replay will be available for ...

New research highlights how air pollution exacerbates heart failure, revealing increased inflammation and the need for ...

Icotrokinra, formerly known as JNJ-2113, is an investigational oral peptide that blocks the interleukin (IL)-23 receptor, which plays a significant role in the pathogenesis of moderate to severe ...